IllumiNeuro Blend 48mg – PE-22-28 10mg + Pinealon 10mg + N-Acetyl Semax 20mg + N-Acetyl Selank 8mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

IllumiNeuro is a multi-component research peptide blend developed for laboratory investigation of neuropeptide signalling, receptor-interaction dynamics and central nervous system communication models. This lyophilized 48 mg preparation combines four analytically verified peptides in a precisely quantified formulation, supporting reproducible in vitro research focused on neurochemical pathway modelling and peptide-mediated signalling systems.

Peptide Overview

This formulation contains N-Acetyl Selank and N-Acetyl Semax, two well-characterised synthetic neuropeptides studied since the late 1990s for their involvement in neurochemical signalling balance and receptor-binding behaviour. PE-22-28, a peptide fragment derived from adrenocorticotropic hormone research, has been investigated for its role in neuronal signalling models, while Pinealon, a short tripeptide, has been studied in laboratory environments for its relevance in neurocellular regulation and peptide–receptor interaction research.

When evaluated together, these peptides allow researchers to explore coordinated neuropeptide signalling behaviour, multi-pathway interaction models and temporal response patterns within central nervous system–related biochemical systems.

Historical Background and Scientific Context

From the late twentieth century onward, research into regulatory neuropeptides expanded as laboratories sought to better understand peptide-based signalling mechanisms within the central nervous system. Multi-peptide research blends incorporating Selank-, Semax- and Pinealon-derived sequences have since been used in preclinical research frameworks examining neurochemical modulation, signalling balance and peptide-driven communication pathways under controlled experimental conditions.

Mechanistic Focus in Research

• Neuropeptide signalling and receptor-interaction modelling
• Central nervous system communication pathway research
• Peptide-mediated neurochemical modulation studies
• Comparative multi-peptide structure–function evaluation
• Controlled in vitro neurobiological investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms full validation for Batch GF102025051. Key analytical results include:

• N-Acetyl Selank Assay Content: 9.89 mg (RT 0.992)
• N-Acetyl Semax Assay Content: 20.1 mg (RT 0.994)
• PE-22-28 Assay Content: 9.99 mg (RT 0.992)
• Pinealon Assay Content: 12.92 mg (RT 0.998)
• Endotoxins: below 0.001 EU per mg
• Bioburden: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures, ensuring transparent documentation and complete batch traceability.

Research Applications

• Neuropeptide signalling and receptor-binding research
• Central nervous system pathway modelling
• Neurochemical modulation and feedback studies
• Multi-peptide interaction and synergy evaluation
• Controlled in vitro neurobiological investigations

Grail Formula Quality

Every Grail Formula research peptide blend undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for low endotoxin levels, analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity multi-peptide neuroresearch blend
Validated assay content of four analytically verified peptides
Retention time identification and full COA traceability
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.